Paul Tudor Jones’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.2M Buy
+31,109
New +$2.02M ﹤0.01% 1598
2025
Q4
Sell
-25,465
Closed -$717K 4068
2025
Q3
$717K Buy
+25,465
New +$771K ﹤0.01% 2487
2024
Q4
Sell
-38,706
Closed -$1.75M 3521
2024
Q3
$1.75M Buy
+38,706
New +$1.84M 0.01% 1278
2024
Q2
Sell
-33,862
Closed -$1.16M 2811
2024
Q1
$1.16M Sell
33,862
-8,812
-21% -$318K 0.01% 1260
2023
Q4
$1.57M Buy
+42,674
New +$987K 0.01% 1229
2023
Q3
Sell
-28,152
Closed -$576K 2887
2023
Q2
$576K Buy
28,152
+1,783
+7% +$26.7K 0.01% 1632
2023
Q1
$398K Sell
26,369
-2,056
-7% -$45.4K 0.01% 1753
2022
Q4
$677K Buy
28,425
+16,626
+141% +$482K 0.01% 1385
2022
Q3
$416K Buy
+11,799
New +$501K 0.01% 1534
2022
Q2
Sell
-11,186
Closed -$552K 2522
2022
Q1
$552K Buy
11,186
+76
+0.7% +$4.21K 0.01% 1218
2021
Q4
$860K Buy
11,110
+5,256
+90% +$539K 0.01% 1103
2021
Q3
$626K Buy
+5,854
New +$670K 0.01% 1506
2021
Q2
Sell
-6,543
Closed -$810K 1950
2021
Q1
$810K Buy
+6,543
New +$994K 0.02% 937

Other funds holding TWST

Paul Tudor Jones's TWST Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Twist Bioscience (TWST) in Q2 2026: 31,109 shares worth $3.2M. The stake represents ﹤0.01% of the portfolio and ranks #1598 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in TWST as recently as Q3 2025.

Paul Tudor Jones first reported a position in TWST in Q1 2021 and has held it in 13 quarters since. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Paul Tudor Jones held 31,109 shares of Twist Bioscience worth $3.2M as of Q2 2026.
  • Twist Bioscience was a new Paul Tudor Jones position in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1598 holding.
  • Paul Tudor Jones first reported a position in Twist Bioscience in Q1 2021 and has held it in 13 quarters since.
  • 334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.